Caffeine Monohydrate | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Caffeine Monohydrate
Canada

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

Contact Supplier

Inke S.A: APIs manufacturing plant.

Contact Supplier

Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Caffeine Monohydrate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

67 API Suppliers, 10 USDMF, 10 CEP/COS, 11 JDMF, 1 EU WC, 6 KDMF, 18 NDC API, 31 Listed Suppliers, $ API Reference Price

67 API Suppliers
10 USDMF
10 CEP/COS
11 JDMF
1 EU WC
6 KDMF
18 NDC API
31 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

64 Drugs in Development

64 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

482 FDF Dossiers, 126 FDA Orange Book, 104 Europe, 30 Canada, 133 South Africa, 89 Listed Dossiers

482 FDF Dossiers
126 FDA Orange Book
104 Europe
30 Canada
133 South Africa
89 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 356.4MG;30MG;16MG, TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET;ORAL - 250MG;250MG;65MG, TABLET;ORAL - 100MG;1MG, TABLET;ORAL - 325MG;50MG;40MG, SUPPOSITORY;RECTAL - 100MG;2MG, TABLET;ORAL - 325MG;50MG;40MG

CAPSULE;ORAL - 356.4MG;30MG;16MG
TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 325MG;50MG;40MG;30MG
CAPSULE;ORAL - 325MG;50MG;40MG;30MG
TABLET;ORAL - 250MG;250MG;65MG
TABLET;ORAL - 100MG;1MG
TABLET;ORAL - 325MG;50MG;40MG
SUPPOSITORY;RECTAL - 100MG;2MG
TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 1 Evonik, 13 Rochem International Inc, 31 SPI Pharma, 31 DKSH, 2 Pharm-RX Chemical, 9 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 1 ICE Pharma, 16 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 1 Capital Farma, 13 Kirsch Pharma, 4 ACG Worldwide, 21 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Ashland, 46 BASF, 1 Bioplus Life Sciences, 3 CD Formulation, 4 Clariant, 13 Corel Pharma Chem, 7 DFE Pharma, 2 Esteem Industries, 3 Finar, 15 Gangwal Chemicals, 1 Hayashibara, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 4 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 2 Lubrizol Life Science Health, 26 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 11 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 46 Roquette, 20 Seppic, 3 Shandong Focus Biotechnology Co., Ltd, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 1 Symrise, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 3 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

110 Fillers, Diluents & Binders, 75 Thickeners and Stabilizers, 61 Coating Systems & Additives, 61 Topical, 58 Solubilizers, 49 Disintegrants & Superdisintegrants, 49 Direct Compression, 46 Parenteral, 45 Taste Masking, 42 Granulation, 33 Controlled & Modified Release, 30 Film Formers & Plasticizers, 27 Lubricants & Glidants, 27 Emulsifying Agents, 26 Chewable & Orodispersible Aids, 20 Surfactant & Foaming Agents, 18 Rheology Modifiers, 18 Co-Processed Excipients, 12 API Stability Enhancers, 9 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

110 Fillers, Diluents & Binders
75 Thickeners and Stabilizers
61 Coating Systems & Additives
61 Topical
58 Solubilizers
49 Disintegrants & Superdisintegrants
49 Direct Compression
46 Parenteral
45 Taste Masking
42 Granulation
33 Controlled & Modified Release
30 Film Formers & Plasticizers
27 Lubricants & Glidants
27 Emulsifying Agents
26 Chewable & Orodispersible Aids
20 Surfactant & Foaming Agents
18 Rheology Modifiers
18 Co-Processed Excipients
12 API Stability Enhancers
9 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

33 News #PharmaBuzz

33 News #PharmaBuzz

GLOBAL SALES INFORMATION

38 US Medicaid Prescriptions, 6 Regulatory FDF Prices

38 US Medicaid Prescriptions
6 Regulatory FDF Prices

MARKET PLACE

89 APIs, 4 FDF Dossiers

89 APIs
4 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 2 JP, 15 Others

2 EDQM
2 JP
15 Others

ANALYTICAL

1 BioAnalytical Methods, 13 Analytical Methods

1 BioAnalytical Methods
13 Analytical Methods

$ API Ref.Price (USD/KG) : 16 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

30 All

01 3APOTEX INC

02 3ARALEZ PHARMACEUTICALS CANADA INC

03 1BAYER INC

04 1CHIESI FARMACEUTICI S.P.A.

05 2KENVUE CANADA INC.

06 2LABORATOIRE RIVA INC.

07 2OMEGA LABORATORIES LIMITED

08 7Pharmascience Inc.

09 8TEVA CANADA LIMITED

10 1VITA HEALTH PRODUCTS INC

filter Active Ingredients Reset all filters

30 All

01 20CAFFEINE

02 3CAFFEINE CITRATE

03 7Caffeine

filter Dosage Form Reset all filters

30 All

01 9CAPSULE

02 3SOLUTION

03 18TABLET

filter Brand Name Reset all filters

30 All

01 1A.C.& C TABLETS

02 1AC&C TABLETS

03 1ACETAMINOPHEN 500 MG COMPOUND TABLETS WITH CODEINE

04 1ACETAMINOPHEN WITH CODEINE - CAPLET

05 1ACETAMINOPHEN, CAFFEINE & 8MG CODEINE PHOSPHATE

06 2ACETAMINOPHEN, CAFFEINE & CODEINE

07 1ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE TABLETS

08 1APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE

09 1APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE-CODEINE-C 1/2

10 1APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE-CODEINE-C 1/4

11 1C-2 BUFFERED WITH CODEINE

12 1CAFFEINE CITRATE INJECTION USP

13 1CAFFEINE CITRATE ORAL SOLUTION USP

14 1EXTRA STRENGTH TYLENOL DAYTIME RELIEF

15 1FIORINAL

16 1FIORINAL-C 1/2

17 1FIORINAL-C 1/4

18 1MIDOL COMPLETE

19 1PEYONA

20 1TEVA-LENOLTEC NO. 1

21 1TEVA-LENOLTEC NO. 2

22 1TEVA-LENOLTEC NO. 3

23 2TEVA-TECNAL

24 1TEVA-TECNAL C 1/2

25 1TEVA-TECNAL C 1/4

26 1TRIANAL TABLET

27 1TYLENOL ULTRA RELIEF

28 1ULTRA HEADACHE RELIEF

List of Suppliers

Product Main Page

01

ARALEZ PHARMACEUTICALS CANADA INC

OTS 2025

Not Confirmed

ARALEZ PHARMACEUTICALS CANADA INC

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Brand Name : FIORINAL-C 1/4

Dosage Form : CAPSULE

Dosage Strength : 40MG

Packaging : 100

Approval Date :

Application Number : 176192

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ARALEZ PHARMACEUTICALS CANADA INC

OTS 2025

Not Confirmed

ARALEZ PHARMACEUTICALS CANADA INC

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Brand Name : FIORINAL-C 1/2

Dosage Form : CAPSULE

Dosage Strength : 40MG

Packaging : 100/500

Approval Date :

Application Number : 176206

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ARALEZ PHARMACEUTICALS CANADA INC

OTS 2025

Not Confirmed

ARALEZ PHARMACEUTICALS CANADA INC

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : CONTROLLED DRUGS (CDSA IV)

Registration Country : Canada

Brand Name : FIORINAL

Dosage Form : CAPSULE

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number : 226327

Regulatory Info : CONTROLLED DRUGS (CDSA IV)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Pharmascience Inc.

OTS 2025

Not Confirmed

Pharmascience Inc.

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Brand Name : A.C.& C TABLETS

Dosage Form : TABLET

Dosage Strength : 15MG

Packaging : 50/100/200

Approval Date :

Application Number :

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Pharmascience Inc.

OTS 2025

Not Confirmed

Pharmascience Inc.

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Brand Name : ACETAMINOPHEN, CAFFEINE & CODEINE

Dosage Form : TABLET

Dosage Strength : 15MG

Packaging : 50

Approval Date :

Application Number :

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Pharmascience Inc.

OTS 2025

Not Confirmed

Pharmascience Inc.

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Brand Name : ACETAMINOPHEN, CAFFEINE & CODEINE

Dosage Form : TABLET

Dosage Strength : 15MG

Packaging : 50

Approval Date :

Application Number :

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Pharmascience Inc.

OTS 2025

Not Confirmed

Pharmascience Inc.

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Brand Name : ACETAMINOPHEN 500 MG COMPOUND TABLETS WITH CODEINE

Dosage Form : TABLET

Dosage Strength : 15MG

Packaging : 60

Approval Date :

Application Number :

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Pharmascience Inc.

OTS 2025

Not Confirmed

Pharmascience Inc.

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Brand Name : C-2 BUFFERED WITH CODEINE

Dosage Form : TABLET

Dosage Strength : 15MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Pharmascience Inc.

OTS 2025

Not Confirmed

Pharmascience Inc.

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Brand Name : ACETAMINOPHEN, CAFFEINE & 8MG CODEINE PHOSPHATE

Dosage Form : TABLET

Dosage Strength : 15MG

Packaging : 50/100/200

Approval Date :

Application Number :

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Pharmascience Inc.

OTS 2025

Not Confirmed

Pharmascience Inc.

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Brand Name : AC&C TABLETS

Dosage Form : TABLET

Dosage Strength : 15MG

Packaging : 50/100/200

Approval Date :

Application Number :

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!